Our spokespeople are experts in their field and are available to comment on a wide range of cancer–related topics.

CEO and Chief Cancer Officer

Professor David Currow

Expert areas: cancer research, treatment, services and public health, statistics, facts and data, prevention, risk and awareness, system improvement, translational research.

Professor David Currow FAHMS is the Chief Cancer Officer of NSW and Chief Executive Officer of the Cancer Institute NSW, the NSW Government’s cancer control agency.

Prior to his appointment to the position in March 2010, Professor Currow was the foundation Chief Executive Officer of Cancer Australia, the Commonwealth's cancer control agency.

Professor Currow leads the Cancer Institute NSW team, whose expertise and remit include:

  • cancer prevention
  • early detection and screening
  • cancer service performance
  • reporting and development
  • strategic investment in translational cancer research.

Through these vital areas, Professor Currow advances the role of the Cancer Institute NSW in its capacity to:

  • decrease the incidence of cancer
  • increase the survival for people who are diagnosed with cancer
  • improve the quality of care for people with cancer.

Cancer outcomes continue to improve as a result of whole-of-system changes.

Professor Currow is a Fellow of the Australian Academy of Health and Medical Sciences (FAHMS). He is past president of the Clinical Oncological Society of Australia and Palliative Care Australia.
He has also:

  • served on the American Society of Clinical Oncology working party on palliative care education.
  • chaired the working party for the Union of International Cancer Control on Palliative Care for the United Nations summit on non-communicable diseases.
  • been on faculty for the Australia & Asia Pacific Clinical Oncology Research Development workshops (ACORD).

Professor Currow appears regularly in the media, both in NSW and nationally, to discuss advances in cancer research, treatment and control.

Director of Cancer Screening and Prevention

Sarah McGill

Expert areas: screening and detection, prevention, risk and awareness, tobacco and smoking, skin cancer and UV protection.

Sarah McGill took on the role of Director of Cancer Screening and Prevention at the Cancer Institute NSW in 2012. She oversees activities including:

  • anti-tobacco and skin cancer mass media campaigns
  • symptom awareness projects
  • statewide breast, cervical and bowel screening programs.  

Sarah has extensive experience in the public health system in New Zealand, having held a number of strategic and operational roles throughout her career. She has significant experience in change management and service redesign. Sarah has been responsible for providing leadership, management and accountability for a wide range of:

  • clinical services and clinical governance
  • patient safety
  • quality and risk services.

Sarah is a Registered Nurse and holds a Master of Public Policy and Post Graduate Diploma in Business Management.